Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Pancreatic Cancer Global Clinical Trials Review, H1, 2017


  • Products Id :- GDHC4088CTIDB
  • |
  • Pages: 1492
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, "Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Subjects Recruited Over a Period of Time 25

Clinical Trials by Sponsor Type 26

Prominent Sponsors 27

Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials 28

Prominent Drugs 29

Latest Clinical Trials News on Pancreatic Cancer 30

Feb 21, 2017: Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate 30

Feb 21, 2017: Spring Bank Pharmaceuticals to Present Results from In Vivo Studies of SB 11285, a Novel STING agonist for Immuno-Oncology, at Keystone Symposia 30

Feb 21, 2017: PharmaCyte Biotech Discusses Patient Enrollment and TD2s Role in Upcoming Clinical Trial 30

Feb 02, 2017: Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients 31

Jan 27, 2017: Redx outlines growing opportunity for Porcupine inhibitors 32

Jan 20, 2017: ARMO BioSciences Presents New Phase 1b Clinical Data for AM0010 in Advanced Pancreatic Cancer Patients at 2017 Gastrointestinal Cancers Symposium 32

Jan 20, 2017: Pamrevlumab Pancreatic Cancer Clinical Data Presented at ASCO 2017 Gastrointestinal Cancers Symposium 33

Jan 20, 2017: ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor CCX872 in Patients with Advanced Non-Resectable Pancreatic Cancer 33

Jan 17, 2017: BioLineRx Announces Initiation of Immuno-Oncology Phase 2 Study to Investigate Combination of BL-8040 and KEYTRUDA for Pancreatic Cancer 34

Jan 11, 2017: Celyad Announces Registration of the First Pancreatic Cancer Patient in its CAR-T NKR-2THINK Trial in Belgium 35

Jan 05, 2017: Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints 35

Dec 23, 2016: Anti-AXL Biologic Increases Tumor Sensitivity to Radiation and Check-Point Inhibitors 36

Dec 22, 2016: Propanc Commences GLP-Compliant 28-Day Repeat-Dose Toxicity Study 36

Dec 12, 2016: PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial 36

Clinical Trial Profile Snapshots 38

Appendix 1489

Abbreviations 1489

Definitions 1489

Research Methodology 1490

Secondary Research 1491

About GlobalData 1491

Contact Us 1491

Disclaimer 1492

Source 1492

List of Figures

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10

Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11

Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12

Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13

Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14

Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26

Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

GlobalData Methodology 1490

List of Tables

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 7

Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10

Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11

Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 12

Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13

Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14

Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19

Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 21

Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22

Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23

Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24

Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25

Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26

Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27

Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28

Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc, Sanofi, AstraZeneca Plc, Celgene Corp, Eli Lilly and Company, Merck & Co Inc, AbbVie Inc, Otsuka Holdings Co Ltd

select a license

Single User License
USD 2500 INR 160050
Site License
USD 5000 INR 320100
Corporate User License
USD 7500 INR 480150

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com